Biogen Investigates Death of Aduhelm Patient; Company is exploring whether the death of the 75-year-old, who experienced brain swelling, is linked to use of the Alzheimer's drug
The Wall Street journal. Eastern edition, 2021-11-09Copyright 2021 Dow Jones & Company, Inc. All Rights Reserved. ;EISSN: 2574-9579
Digital Resources/Online E-Resources